Program Overview
ON-DEMAND VIDEO/ENDURING PROGRAM AVAILABLE ONLINE THRU APRIL 27, 2024
Learning
Objectives
-Discuss the prevalence and pathogenesis of cardiorenal complications.
-Discuss current guidelines for optimal management of diabetic patients to prevent and treat cardiorenal complications.
-Discuss the mechanism of action and indications/contraindications of GLP1-agonists and SGLT2-inhibitors.
Joint Accreditation Statement
In support of
improving patient care, this activity has been planned and implemented by
Amedco LLC and Columbia University.
Amedco LLC is jointly accredited by the Accreditation Council for
Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy
Education (ACPE), and the American Nurses Credentialing Center (ANCC), to
provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.
Physicians (ACCME) Credit Designation Statement
Amedco LLC designates this live virtual activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants
PAs may claim a maximum of 4.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Maximum of 4.0 hours.